Trial NCT02322281

View at ClinicalTrials.gov 
Org. Study IDs: CO-1686-020 (TIGER-3)

Last trial update was posted on 2019-08-14

MeSH Interventions

Docetaxel Gemcitabine Paclitaxel Pemetrexed

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-small Cell Lung Cancer

Stopping Reasons

Sponsor discontinued development of CO-1686 for NSCLC

Limitations And Caveats

Due to early study termination, only 149 of 600 planned patients were randomized.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID